Company / Total Assets
AXIM BIOTECHNOLOGIES, INC. Total Assets History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$4.1M
FY2023
5-year range
$1.4M / $4.2M
FY2019-FY2023
Trend
-2.1%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 9 years, ranging from $56,823 in FY2013 to $4M in FY2022.
Based on SEC 10-K filings.
$4M in FY2023 with a 10-year CAGR of +53.5%.
Improved from $2M to $4M over the past 5 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +14.6%
- 10-Year CAGR
- +53.5%
Key checks
Key Insights
- 5-year CAGR of +14.6%, indicating consistent growth.
- In FY2023, total assets decreased 2.1% year-over-year.
- Peak total assets was recorded in FY2022.
- Lowest total assets in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $4.1M | -2.1% |
| FY2022 | $4.2M | +101.6% |
| FY2018 | $2.1M | -4.7% |
| FY2017 | $2.2M | +51.3% |
| FY2016 | $1.4M | +14.9% |
| FY2015 | $1.3M | +2120.2% |
| FY2013 | $56.8K | -57.2% |
| FY2012 | $132.8K | -3.3% |
| FY2011 | $137.3K | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026